Colorado Community Institutional Review Board
What Is an Institutional Review Board
(IRB)?
An IRB is an independent committee designated by an
organization to assure that the rights and welfare of people
participating in research studies are protected. The Colorado
Cancer Research Program has designated the Colorado Community
IRB (CCIRB) to review the research studies it participates in,
whether sponsored by the National Cancer Institute or other
sponsors.
An IRB consists of at least five members of varying
backgrounds. IRB members have the professional experience to
provide appropriate scientific and ethical review. An IRB must
have at least one scientist member and at least one member whose
primary experience is nonscientific. There must also be members
from the community, representing both gender and racial
diversity. The members of the Colorado Community IRB include
retired physicians (cancer specialists) and legal, educational,
and research professionals, as well as cancer patients.
Where Does an IRB Get Its Authority?
In 1974, the Department of Health and Human Services created
regulations regarding the protection of human subjects through
the establishment of IRBs, which are overseen on the federal
level by the HHS Office for Human Research Protections (OHRP).
OHRP assists IRBs in their work and receives and investigates
claims of inappropriate research practices.
^Top of Page
How Does an IRB Make Its Decisions?
Before a physician researcher can enroll patients in a
research study, the protocol (research procedures) is reviewed
by the IRB. The researcher provides the IRB with all the
necessary materials to conduct a review, including a full
description of the proposed project and treatment drugs, other
materials to be used such as questionnaires, a description of
the manner in which subjects will be enrolled and a detailed
consent form. The IRB examines all these materials to determine
if the research participants are adequately informed and
protected.
^Top of Page
What Does an IRB Do after
Reviewing the Project?
After examining the materials the researcher provides to the
IRB, the committee members must decide if the benefits of the
research are maximized and the risks minimized, and make a final
determination whether the benefits justify the risks to the
participants. If the IRB finds that this is the case, they may
approve the study. Alternatively, the IRB may request that the
researcher make specific changes to the procedures or consent
form and approve the protocol contingent on these changes.
Finally, the IRB may decide to disapprove of the project. In
addition to reviewing new research protocols, IRBs also review
continuing projects or those that have changes in their
procedures. Continuing projects are reviewed yearly, or more
often if the IRB feels it is necessary.
^Top of Page
|